National Comprehensive Cancer Network



About NCCN

Hodgkin Lymphoma Panel - Disclosures as of 5/25/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Ranjana H. Advani, MD

Genentech, Inc.;
GlaxoSmithKline;
Jannsen Pharmaceutica Products, LP;
Allos Therapeutics;
Seattle Genetics;
Pharmacyclics

Celgene Corporation;
Sanofi Oncology;
Seattle Genetics

None

None

9/21/2012

Weiyun Z. Ai, MD

None

None

None

None

4/1/2012

Richard F. Ambinder, MD, PhD

None

None

None

None

5/21/2012

Patricia Aoun, MD, MPH

None

None

None

None

3/26/2013

Celeste M. Bello, MD, MSPH

Seattle Genetics

Seattle Genetics;
Spectrum Pharmaceuticals

None

None

8/10/2012

Cecil M. Benitez, BS

None

None

None

None

8/24/2012

Philip J. Bierman, MD

Otsuka Pharmaceuticals;
Seattle Genetics

None

None

None

5/1/2013

Kristie A. Blum, MD

AstraZeneca Pharmaceuticals LP;
Celgene Corporation;
Novartis Pharmaceuticals Corporation;
Pharmacyclics

None

None

None

8/29/2012

Robert Chen, MD

Seattle Genetics

Millennium Pharmaceuticals, Inc.;
Seattle Genetics

None

None

8/29/2012

Bouthaina Dabaja, MD

None

None

None

None

11/8/2012

Richard I. Fisher, MD

None

Boehringer Ingelheim GmbH;
Bio Linx;
Hoffman LaRoche;
Micromet;
Pfizer Inc.

None

None

3/19/2013

Andres Forero, MD

Abbott Laboratories;
Biogen Idec;
Celgene Corporation;
Daiichi- Sankyo Co.;
Eisai Inc.;
Eli Lilly and Company;
Genentech, Inc.;
BioCryst;
Immunomedics;
Seattle Genetics

None

None

None

5/5/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Leo I. Gordon, MD

CureTech Ltd.;
Genentech, Inc.

CureTech Ltd.

None

CureTech Ltd.

6/20/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Francisco Hernandez-Ilizaliturri, MD

None

Amgen Inc.;
Celgene Corporation

None

None

8/30/2012

Ephraim P. Hochberg, MD

None

Genentech, Inc.;
Proventys/NCCN

None

Seatle Genetics

10/9/2012

Richard T. Hoppe, MD

None

None

None

Takeda Pharmaceuticals North America, Inc.

2/28/2013

David G. Maloney, MD, PhD

None

None

None

None

8/10/2012

David Mansur, MD

None

None

None

None

9/23/2011

Peter Mauch, MD

None

None

None

None

2/28/2013

Joan S. McClure, MS

None

None

None

None

7/23/2012

Monika Metzger, MD

None

None

None

None

9/17/2012

Joseph O. Moore, MD

ARIAD Pharmaceuticals, Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

Amgen Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

8/24/2012

David Morgan, MD

None

seattle genetics

None

None

12/8/2011

Craig H. Moskowitz, MD

Cephalon, Inc.;
Eli Lilly and Company;
Genentech, Inc.;
Plexxicon;
seattle genetics

GlaxoSmithKline;
Seattle Genetics;
Roche Laboratories, Inc.

None

None

9/5/2012

Matthew Poppe, MD

None

None

None

None

8/10/2012

Hema Sundar, PhD

None

None

None

None

2/25/2013

Jane N. Winter, MD

None

Novartis Pharmaceuticals Corporation

None

None

11/7/2011

Joachim Yahalom, MD

None

None

None

None

2/8/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved